Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 16, Number 8—August 2010


Hantavirus Infections in Humans and Animals, China

Yong-Zhen ZhangComments to Author , Yang Zou, Zhen F. Fu, and Alexander Plyusnin
Author affiliations: State Key Laboratory for Infectious Disease Control and Prevention, Beijing, People’s Republic of China (Y.-Z. Zhang, Y. Zou); University of Georgia, Athens, Georgia, USA (Z.F. Fu); University of Helsinki, Helsinki, Finland (A. Plyusnin)

Main Article

Table 3

Inactivated hantavirus vaccines used in China, 1995–2010

Virus Cell culture used Vaccination procedure* Protection, %
Hantaan Mongolian gerbil kidney 3 + 1 >90
Seoul Golden hamster kidney 2 + 1 >95
Hantaan Suckling mouse brain 3 + 1 >90
Hantaan/Seoul Mongolian gerbil kidney 2 + 1 >95
Hantaan/Seoul Vero 2 + 1 >85†

*No. doses + no. boosters.
†Seroconversion rate of human hantavirus antibody determined by plaque-reduction neutralization test.

Main Article